United States - English - NLM (National Library of Medicine)

validus pharmaceuticals llc - methenamine hippurate (unii: m329791l57) (methenamine - unii:j50oix95qv) - hiprex is indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. this drug should only be used after eradication of the infection by other appropriate antimicrobial agents. to reduce the development of drug-resistant bacteria and maintain the effectiveness of hiprex and other antibacterial drugs, hiprex should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. hiprex (methenamine hippurate tablets usp) is contraindicated in patients with renal insufficiency, severe hepatic insufficiency, or severe dehydration. methenamine preparations should not be given to patients taking sulfonamides becau

United States - English - NLM (National Library of Medicine)

validus pharmaceuticals llc - methenamine hippurate (unii: m329791l57) (methenamine - unii:j50oix95qv) - hiprex is indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when long-term therapy is considered necessary. this drug should only be used after eradication of the infection by other appropriate antimicrobial agents. to reduce the development of drug-resistant bacteria and maintain the effectiveness of hiprex and other antibacterial drugs, hiprex should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. hiprex (methenamine hippurate tablets usp) is contraindicated in patients with renal insufficiency, severe hepatic insufficiency, or severe dehydration. methenamine preparations should not be given to patients taking sulfonamides becau

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - methenamine hippurate 1 g (1.005g hexamine hippurate with aerosil);  ;  ;   - tablet - 1 g - active: methenamine hippurate 1 g (1.005g hexamine hippurate with aerosil)       excipient: magnesium stearate povidone - label claim: prophylaxis or supression of urinary tract bacteria

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - methenamine hippurate, quantity: 1 g - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; povidone; magnesium stearate - supression or elimination of bacteriuria associated with chronic or recurrent infection of the urinary tract, especially when long term therapy is indicated.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - methenamine hippurate - oral tablet - 1gram

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

inova pharmaceuticals (singapore) pte ltd (incorporated in singapore) malaysia branch - hexamine hippurate -

United States - English - NLM (National Library of Medicine)

sanofi-aventis u.s. llc - methenamine hippurate (unii: m329791l57) (methenamine - unii:j50oix95qv) - methenamine hippurate 1 g

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals australia pty ltd - hexamine hippurate -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - methenamine hippurate - oral tablet - 1gram

Ireland - English - HPRA (Health Products Regulatory Authority)

3m health care limited - methenamine hippurate - tablets - 1 grams